The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Chronic Disease Epidemiology In Different Populations: Risk Factors, Detection And Prevention
Funder
National Health and Medical Research Council
Funding Amount
$621,458.00
Summary
To investigate causes, detection and prevention of diabetes, cardiovascular disease, and kidney disease in Aboriginal and international populations, I will maintain a long-term cohort with a 20-year follow-up in Aboriginal people and to analyse several large repeated cross-sectional data collected over 25 years in China. For the next 5 years, I will continue to to provide critical epidemiological evidence for the development of health policies and clinical guidelines related to chronic diseases ....To investigate causes, detection and prevention of diabetes, cardiovascular disease, and kidney disease in Aboriginal and international populations, I will maintain a long-term cohort with a 20-year follow-up in Aboriginal people and to analyse several large repeated cross-sectional data collected over 25 years in China. For the next 5 years, I will continue to to provide critical epidemiological evidence for the development of health policies and clinical guidelines related to chronic diseases in different populations.Read moreRead less
Regenerating The Kidney Using An Understanding Of Normal Development
Funder
National Health and Medical Research Council
Funding Amount
$951,005.00
Summary
In Australia, chronic kidney disease costs >$1 billion per annum, however treatment options for kidney failure have not changed for >50 years. Dialysis reduces quality of life and lifespan while only 1 in 4 patients receives a transplant. Using our understanding of normal kidney formation, this study will generate kidney tissue from human stem cells to better understand inherited kidney diseases and develop novel regenerative therapies for the treatment of end stage kidney disease.
Understanding The Developmental Basis Of Kidney Disease
Funder
National Health and Medical Research Council
Funding Amount
$622,655.00
Summary
Kidney disease is a considerable burden on the health system and much of it derives from events that occur during organ development. In this grant I will investigate why human nephron number varies between people, how renal cysts form and what genes are mutated in patients with congenital kidney malformations.
Exploiting Existing Data Sources To Improve The Prevention And Treatment Of Cardiovascular Disease
Funder
National Health and Medical Research Council
Funding Amount
$772,490.00
Summary
My program of research exploits several large databases to answer important issues in the prevention and treatment of cardiovascular disease (CVD), which makes a huge contribution to the burden of illness and premature mortality in Australia. An underlying aim is to provide the evidence base to facilitate improvement of the existing CVD risk assessment guidelines in Australia, for better targeting of clinical advice and treatment.
Understanding The Kidney: From Morphogenesis To Regeneration
Funder
National Health and Medical Research Council
Funding Amount
$850,346.00
Summary
In Australia, 11.3% of deaths are associated with chronic kidney disease with >$1 billion per annum spent on treating this condition. Kidney function throughout life depends upon what happened during your foetal development as all the functional units of the kidney are made prior to birth. In this project, we will use our understanding of normal kidney development to develop new regenerative approaches to the treatment of this condition.
Although the major risk factors for cardiovascular diseases have been known for decades, and modern-day treatment is much advanced, the importance of these diseases persists, such that they remain the number one killer in Australia. This suggests that more can be done to correctly identify those at high and moderate risk of future disease, so as to optimize advice and medical treatment. This project will use the best evidence available to develop new methods of risk prediction and prevention.
Growing The Evidence Base For Improved Outcomes In Chronic Kidney Disease
Funder
National Health and Medical Research Council
Funding Amount
$697,209.00
Summary
One in eight Australians has kidney disease, and is at increased risk of kidney failure, heart disease and stroke, and premature death. Despite this, very few treatments have been proven to be be effective at improving these outcomes. Professor Perkovic will undertake a suite of high-quality randomised trials and systematic reviews that will reliably identify new treatment approaches that will result in better quality and quantity of life for the millions of Australians affected by kidney diseas ....One in eight Australians has kidney disease, and is at increased risk of kidney failure, heart disease and stroke, and premature death. Despite this, very few treatments have been proven to be be effective at improving these outcomes. Professor Perkovic will undertake a suite of high-quality randomised trials and systematic reviews that will reliably identify new treatment approaches that will result in better quality and quantity of life for the millions of Australians affected by kidney diseaseRead moreRead less
Mechanistic And Translational Studies Targeting Kidney Inflammation And Fibrosis.
Funder
National Health and Medical Research Council
Funding Amount
$697,209.00
Summary
The progression of kidney disease to end-stage renal failure requires support by dialysis or kidney transplantation, leading to reduced quality of life, loss of productivity, and the huge cost of renal replacement therapy in Australia ($1 billion in 2010). This research program focuses on two areas; advancing our understanding of the basic mechanisms of disease pathogenesis, and working with commercial partners to translate my current research effort towards new therapies for kidney disease.
Delineating The Role Of Advanced Glycation In Diabetes And Nephropathy
Funder
National Health and Medical Research Council
Funding Amount
$631,023.00
Summary
Type 1 diabetes affects more than 140,000 Australians and up to 40% of children and adolescents with the disease develop complications including kidney disease. Excess blood sugar as the result of diabetes can accelerate a biochemical process called advanced glycation, which permanently alters proteins affecting their structure and function, which I have previously shown as contributors to kidney damage in diabetes. Recently, however, I have discovered that this biochemical process is also invol ....Type 1 diabetes affects more than 140,000 Australians and up to 40% of children and adolescents with the disease develop complications including kidney disease. Excess blood sugar as the result of diabetes can accelerate a biochemical process called advanced glycation, which permanently alters proteins affecting their structure and function, which I have previously shown as contributors to kidney damage in diabetes. Recently, however, I have discovered that this biochemical process is also involved in the development of type 1 diabetes itself.Read moreRead less
Development Of New Therapies For Respiratory Diseases And Infection
Funder
National Health and Medical Research Council
Funding Amount
$847,490.00
Summary
Prof Hansbro’s group have developed world 1st experimental models of emphysema, severe asthma infection and lung cancer. He uses them to further our understanding of these untreatable diseases. This has led to the development of new potential therapeutic approaches. Now, in discovery programs he will expand studies of pathogenesis to identify new therapeutic targets these diseases. In development and translational programs he will progress new therapies towards clinical application.